This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
ROBBINSVILLE, N.J., Nov. 7, 2013 (GLOBE NEWSWIRE) -- The Drug, Chemical & Associated Technology Association (DCAT) is pleased to announce that
Lori Hoffman, senior director, business development at Sagent Pharmaceuticals, Inc., has been elected by the membership to serve on DCAT's Board of Directors for a three-year term beginning November 1, 2013.
"We look forward to Ms. Hoffman's contributions to the DCAT organization," said Executive Director Margaret Timony. "She brings valuable industry experience and leadership skills that will help shape and support the organization's programs, events and projects."
Founded in 1890, DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries. With over 300 corporate members, DCAT is headquartered in Robbinsville, New Jersey.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.